1 / 1

Case of the week 08-15: Danon disease - A rare cause of LV hypertrophy

Case of the week 08-15: Danon disease - A rare cause of LV hypertrophy. History: 20 years old male, history of RF ablation for WPW syndrome, without prior history of heart failure. Echo : severe hypertrophy of LV with preserved global and regional function. Patient referred for CMR

Download Presentation

Case of the week 08-15: Danon disease - A rare cause of LV hypertrophy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case of the week 08-15: Danon disease - A rare cause of LV hypertrophy History:20 years old male, history of RF ablation for WPW syndrome, without prior history of heart failure.Echo: severe hypertrophy of LV with preserved global and regional function. Patient referred for CMR Cine CMR: severe, symmetric LV hypertrophy without LVOT obstruction, increased LV mass (400 g), long axis impairment and reduced thickening.. Rest perfusion: (“first pass method”; Gd-DTPA 0.1mmol/kg b.w.; 4 ml/s): Significant perfusion defects noted, not all sub-endocardial – atypical for coronary artery disease. Delayed enhancement (DE): Extensive delayed enhancement, not all subendocardial, some matching the perfusion defects. Total volume of delayed enhancement: >25 % of LV muscle volume. CMR interpretation: CMR results suggested a cardiomyopathy with hypertrophy, possibly non-sarcomeric. Cardiac and skeletal muscle biopsies demonstrated Danon’s disease.* Danon's Disease is an X linked glycogen storage disease leading to severe LV hypertrophy and death in young males. The only available form of treatment is cardiac transplantation. *Stained using monoclonal antisera against N-terminal of dystrophin and antisera against LAMP-2. In immunohistochemical analysis the vacuolar membrane seen in skeletal muscle was decorated with antibody against dystrophin and such vacuoles were negative for LAMP-2. Refernece: Yang et al. Danon Disease as an Underrecognized Cause of Hypertrophic Cardiomyopathy in Children. Circulation. 2005;112:1612-1617 (full text) Dorota Piotrowska-Kownacka, Lukasz Kownacki, Leszek Krolicki. Medical University of Warsaw

More Related